A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs C 82 (Primary)
  • Indications Systemic scleroderma
  • Focus Adverse reactions; Biomarker; Pharmacodynamics
  • Sponsors PRISM Pharma Co
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top